Rockwell Medical to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference
2024年7月15日 - 7:45PM
ビジネスワイヤ(英語)
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a
healthcare company that develops, manufactures, commercializes, and
distributes a portfolio of hemodialysis products to dialysis
providers worldwide, announced that the Company's President and
Chief Executive Officer, Dr. Mark Strobeck, will present at the
H.C. Wainwright 3rd Annual Kidney Conference, which is being held
today virtually. For more information, visit
hcwevents.com/kidneyconference.
A webcast of Rockwell Medical's presentation can be accessed
through the Company's "Investors" page at IR.RockwellMed.com and
will be available for 30 days following the conference.
About Rockwell Medical
Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company
that develops, manufactures, commercializes, and distributes a
portfolio of hemodialysis products for dialysis providers
worldwide. Rockwell Medical's mission is to provide dialysis
clinics and the patients they serve with the highest quality
products supported by the best customer service in the industry.
Rockwell is focused on innovative, long-term growth strategies that
enhance its products, its processes, and its people, enabling the
Company to deliver exceptional value to the healthcare system and
provide a positive impact on the lives of hemodialysis patients.
Hemodialysis is the most common form of end-stage kidney disease
treatment and is usually performed at freestanding outpatient
dialysis centers, at hospital-based outpatient centers, at skilled
nursing facilities, or in a patient’s home. Rockwell Medical's
products are vital to vulnerable patients with end-stage kidney
disease, and the Company is relentless in providing unmatched
reliability and customer service. Rockwell Medical is the largest
supplier of liquid bicarbonate concentrates and the second largest
supplier of acid and dry bicarbonate concentrates for dialysis
patients in the United States and has the vision of becoming the
leading global supplier of all hemodialysis concentrates. Certified
as a Great Place to Work® in 2023 and 2024, Rockwell Medical is
Driven to Deliver Life-Sustaining Dialysis SolutionsTM. For more
information, visit www.RockwellMed.com.
Forward-Looking Statements
Certain statements in this press release may constitute
"forward-looking statements" within the meaning of the federal
securities laws. Words such as, "may," "might," "will," "should,"
"believe," "expect," "anticipate," "estimate," "continue," "could,"
"can," "would," "develop," "plan," "potential," "predict,"
"forecast," "project," "intend," "look forward to," "remain
confident," “are determined,” “are on track,” “are resolute in our
vision,” “aim to,” or the negative of these terms, and similar
expressions, or statements regarding intent, belief, or current
expectations, are forward looking statements. There can be no
assurance that Rockwell Medical will become the leading global
supplier of hemodialysis concentrates. While Rockwell Medical
believes these forward-looking statements are reasonable, undue
reliance should not be placed on any such forward-looking
statements, which are based on information available to us on the
date of this release. These forward-looking statements are based
upon current estimates and assumptions and are subject to various
risks and uncertainties (including, without limitation, those set
forth in Rockwell Medical's SEC filings), many of which are beyond
our control and subject to change. Actual results could be
materially different. Risks and uncertainties include, but are not
limited to those risks more fully discussed in the "Risk Factors"
section of our Annual Report on Form 10-K for the year ended
December 31, 2023, as such description may be amended or updated in
any future reports we file with the SEC. Rockwell Medical expressly
disclaims any obligation to update our forward-looking statements,
except as may be required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240715436309/en/
Heather R. Hunter SVP, Chief Corporate Affairs Officer (248)
432-1362 IR@RockwellMed.com
Rockwell Medical (NASDAQ:RMTI)
過去 株価チャート
から 7 2024 まで 8 2024
Rockwell Medical (NASDAQ:RMTI)
過去 株価チャート
から 8 2023 まで 8 2024